• Home
  •  / NanoCarrier

NanoCarrier

OverviewSuggest Edit

NanoCarrier (ナノキャリア株式会社) is a company engaged in the research and development of pharmaceuticals using micellar nanoparticle technology. Its main products include NC-6004, a Cisplatin-based formulation for the treatment of pancreatic, head and neck, non-small cell lung, bladder, and biliary tract cancers, and NC-4016, a DachPt micelle formulation for solid cancers.
TypePublic
Founded1996
HQ柏市, JPMap
Websitenanocarrier.co.jp

Locations

NanoCarrier is headquartered in
柏市, Japan

Location Map
All Locations (2)

Latest Updates

Employees (est.) (Dec 2021)27(-6%)
Share Price (May 2022)¥226
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at NanoCarrier

Tetsuhito Matsuyama

Tetsuhito Matsuyama

President & CEO
Shiro Akinaga

Shiro Akinaga

Director
Teruo Okano

Teruo Okano

Director
Koji Fujimoto

Koji Fujimoto

Managing Director of Corporate Division
Kazunori Kataoka

Kazunori Kataoka

Director
Show more

NanoCarrier Office Locations

NanoCarrier has offices in 柏市 and Chuo City
柏市, JP (HQ)
144-15 Chuo, 226-39
Chuo City, JP
1-chōme-4-10 Kyōbashi
Show all (2)

NanoCarrier Financials and Metrics

NanoCarrier Revenue

USD

Market capitalization (10-May-2022)

16.1b

Closing stock price (10-May-2022)

226.0

Cash (31-Dec-2021)

3.7b

EV

13.6b
NanoCarrier's current market capitalization is ¥16.1 b.
Annual
JPYFY, 2018FY, 2019FY, 2020FY, 2021

Cash

3.7b4.6b4.5b3.9b

Accounts Receivable

17.5m103.4m94.0m24.1m

Prepaid Expenses

112.5m138.7m185.4m227.1m

Inventories

151.7m32.8m76.1m138.3m
Quarterly
JPYQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Cash

3.0b3.5b3.2b5.1b6.6b6.3b3.2b3.0b4.2b4.1b3.8b3.7b

Accounts Receivable

61.4m196.8m192.2m168.1m146.4m146.5m117.4m76.0m51.7m60.7m45.8m41.8m

Inventories

112.2m118.0m27.9m49.2m42.2m50.4m184.9m136.4m149.0m146.5m188.7m75.8m
show all
Annual
JPYFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

(5.4b)(1.8b)(2.0b)(2.8b)

Depreciation and Amortization

26.4m8.9m926.0k1.8m

Inventories

124.1m118.9m(43.3m)(62.2m)

Accounts Payable

164.0k(10.9m)3.2m
Quarterly
JPYQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022Q3, 2022

Net Income

(907.9m)(894.8m)(2.1b)(973.9m)

Depreciation and Amortization

4.3m463.0k281.0k1.5m

Inventories

33.7m(9.3m)(60.2m)(50.4m)

Accounts Payable

(2.4m)(1.0m)3.4m(2.0m)
show all
Show all financial metrics

NanoCarrier Revenue Breakdown

Embed Graph

NanoCarrier revenue breakdown by business segment: 100.0% from PHARMACEUTICAL DIVERSIFIED

NanoCarrier Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

Learn more about our premium products
SecurityScorecard logo

NanoCarrier Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

Learn more about our premium products
CSRHub logo

NanoCarrier Online and Social Media Presence

NanoCarrier's Trends

Embed Graph

 NanoCarrier Frequently Asked Questions

  • When was NanoCarrier founded?

    NanoCarrier was founded in 1996.

  • Who are NanoCarrier key executives?

    NanoCarrier's key executives are Tetsuhito Matsuyama, Shiro Akinaga and Teruo Okano.

  • How many employees does NanoCarrier have?

    NanoCarrier has 27 employees.

  • Who are NanoCarrier competitors?

    Competitors of NanoCarrier include Gracell, Deciphera Pharmaceuticals and Spectrum Pharmaceuticals.

  • Where is NanoCarrier headquarters?

    NanoCarrier headquarters is located at 144-15 Chuo, 226-39, 柏市.

  • Where are NanoCarrier offices?

    NanoCarrier has offices in 柏市 and Chuo City.

  • How many offices does NanoCarrier have?

    NanoCarrier has 2 offices.